Abstract:ABSTRACT Antimicrobial resistance (AMR) poses a significant worldwide public health crisis that continues to threaten our ability to successfully treat bacterial infections. With the decline in effectiveness of conventional antimicrobial therapies and the lack of new antibiotic pipelines, there is a renewed interest in exploring the potential of metal-based antimicrobial compounds. Antimony-based compounds with a long history of use in medicine have re-emerged as potential antimicrobial agents. We previously synthesized a series of novel organoantimony(V) compounds complexed with cyanoximates with a strong potential of antimicrobial activity against several AMR bacterial and fungal pathogens. Here, five selected compounds were studied for their antibacterial efficacy against three important bacterial pathogens: Pseudomonas aeruginosa , Escherichia coli , and Staphylococcus aureus . Among five tested compounds, SbPh 4 ACO showed antimicrobial activity against all three bacterial strains with the MIC of 50–100 μg/mL. The minimum bactericidal concentration/MIC values were less than or equal to 4 indicating that the effects of SbPh 4 ACO are bactericidal. Moreover, ultra-thin electron microscopy revealed that SbPh 4 ACO treatment caused membrane disruption in all three strains, which was further validated by increased membrane permeability. We also showed that SbPh 4 ACO acted synergistically with the antibiotics, polymyxin B and cefoxitin used to treat AMR strains of P. aeruginosa and S. aureus , respectively, and that at synergistic MIC concentration 12.5 μg/mL, its cytotoxicity against the cell lines, Hela, McCoy, and A549 dropped below the threshold. Overall, the results highlight the antimicrobial potential of novel antimony-based compound, SbPh 4 ACO, and its use as a potentiator of other antibiotics against both Gram-positive and Gram-negative bacterial pathogens. IMPORTANCE Antibiotic resistance presents a critical global public health crisis that threatens our ability to combat bacterial infections. In light of the declining efficacy of traditional antibiotics, the use of alternative solutions, such as metal-based antimicrobial compounds, has gained renewed interest. Based on the previously synthesized innovative organoantimony(V) compounds, we selected and further characterized the antibacterial efficacy of five of them against three important Gram-positive and Gram-negative bacterial pathogens. Among these compounds, SbPh 4 ACO showed broad-spectrum bactericidal activity, with membrane-disrupting effects against all three pathogens. Furthermore, we revealed the synergistic potential of SbPh 4 ACO when combined with antibiotics, such as cefoxitin, at concentrations that exert no cytotoxic effects tested on three mammalian cell lines. This study offers the first report on the mechanisms of action of novel antimony-based antimicrobial and presents the therapeutic potential of SbPh 4 ACO in combating both Gram-positive and Gram-negative bacterial pathogens while enhancing the efficacy of existing antibiotics.

Fusing Bismuth and Mercaptocarboranes: Design and Biological Evaluation of Low‐Toxicity Antimicrobial Thiolato Complexes

Antibacterial performance of heterocyclic organobismuth (III) complexes based on bidentate C,O‐coordinating ligands: Synergism of ligand identity and coordination number

SYNTHESIS, CHARACTERIZATION, PREPARATION AND EVALUATION OF THE BACTERICIDAL POTENTIAL OF TWO Co+2 COMPLEXES USING LIGANDS 4-AMINOPYRIDINE AND 2,2'-BIPYRIDINE

Discovery of antibacterial manganese(i) tricarbonyl complexes through combinatorial chemistry

Synthesis, Characterization, Biological Activity, and Topological Studies

Bismuth(III) bromide-thioamide complexes: synthesis, characterization and cytotoxic properties

Facile synthesis and antifungal evaluation of hypervalent organoantimony(III) and -bismuth(III) thioates with tridentate C,N,C-coordinating ligands

Synthesis via microwave irradiation, structural characterization, and antibacterial activities of new complexes of bismuth(III) with thiosemicarbazones

Natural-Product-Directed Catalytic Stereoselective Synthesis of Functionalized Fused Borane Cluster–Oxazoles for the Discovery of Bactericidal Agents

Mono-cyclopentyl substituted [1,3,4]thiadiazole thione tautomer: study of the spectroscopic, geometric, thermal, and biological properties

Novel antimony-based antimicrobial drug targets membranes of Gram-positive and Gram-negative bacterial pathogens

Synthesis and Anti‐Bacterial Evaluation of Novel Scaffolds Based on Bis‐Thiazole or bis‐1,3,4‐Thiadiazole Linked to Thieno[2,3‐b]Thiophene as New Hybrid Molecules

The pharmacological profile of metal complexes with bis(thiosemicarbazones) and bis(hydrazone)-derived ligands

Structural manifestations and biological screening for newly synthesized heteroleptic bismuth(V) bis-carboxylates

Synthesis, crystal structure, and in vitro biological evaluation of bismuth (III) complexes incorporating pyrazinohydrazide‐derived Schiff bases

Exploring the potential of bis(thiazol-5-yl)phenylmethane derivatives as novel candidates against genetically defined multidrug-resistant Staphylococcus aureus

A study of mononuclear 3d transition metal bis-Schiff base complexes: Synthesis, characterization, and evaluation of their antibacterial activity

Exploration of Rhenium Bisquinoline Tricarbonyl Complexes for their Antibacterial Properties

Unveiling the antibacterial efficacy of thiazolo [3,2-a] pyrimidine: Synthesis, molecular docking, and molecular dynamic simulation

Synthesis and Molecular Docking Study of Some New Thiazole-coumarin Molecular Hybrids as Antibacterial Agents